Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 5, 1997, Pages 622-630

  Taylor Robinson, David ^a   Bébéar, Christiane ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL CELL WALL; BACTERIAL GENE; CELL CULTURE; EUKARYOTIC CELL; GENE MUTATION; GENITAL TRACT INFECTION; GRAM NEGATIVE INFECTION; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; MYCOPLASMA; MYCOPLASMA PNEUMONIAE; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 0030731773     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.5.622     Document Type: Review

References (52)

1. Maniloff, J., McElhaney, R. N., Finch, L R. & Baseman, J. B. (Eds) (1992). Mycoplasmas: Molecular Biology and Pathogenesis. American Society for Microbiology, Washington, DC.
2. Krause, D. C. & Taylor-Robinson, D. (1992). Mycoplasmas which infect humans. In Mycoplasmas: Molecular Biology and Pathogenesis (Maniloff, J., McElhaney, R. N., Finch, L. R. & Baseman, J. B., Eds), pp. 417-44. American Society for Microbiology, Washington, DC.
3. Taylor-Robinson, D. (1995). Mycoplasma and Ureaplasma. In Manual of Clinical Microbiology (Murray, P. R., Barron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 652-62. American Society for Microbiology, Washington, DC.
4. Roberts, M. C. (1992). Antibiotic resistance. In Mycoplasmas: Molecular Biology and Pathogenesis (Maniloff, J., McElhaney, R. N., Finch, L. R. & Baseman, J. B., Eds), pp. 513-23. American Society for Microbiology, Washington, DC.
5. Taylor-Robinson, D. (1967). Mycoplasmas of various hosts and their antibiotic sensitivities. Postgraduate Medical Journal 43, Suppl., 100-4.
6. Taylor-Robinson, D. & Furr, P. M. (1982). The static effect of rosaramicin on Ureaplasma urealyticum and the development of antibiotic resistance. Journal of Antimicrobial Chemotherapy 10, 185-91.
7. Waites, K. B., Crabb, D. M., Duffy, L. B. & Cassell, G. H. (1996). Etest: a novel method for screening Mycoplasma hominis for tetracycline resistance. IOM Letters. Vol. 4. In Program and Abstracts of the 11th International Congress of the International Organization for Mycoplasmology, Orlando, 1996. pp. 408-9.
8. Taylor-Robinson, D. (1983). Metabolism inhibition tests. In Methods in Mycoplasmology, Vol. I (Razin, S. & Tully, J. G., Eds), pp. 411-7. Academic Press, London.
9. Kenny, G. E. & Cartwright, F. D. (1993). Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro. Clinical Infectious Diseases 17, Suppl. 1, S215-8.
10. Eschenbach, D. A., Nugent, R. P., Rao, A. V., Cotch, M. F., Gibbs, R. S., Lipscomb, K. A. et al. (1991). A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. American Journal of Obstetrics and Gynecology 164, 734-42.
11. Kenny, G. E., Cartwright, F. D. & Roberts, M. C. (1986). Agar dilution method for determination of antibiotic susceptibility of Ureaplasma urealyticum. Pediatric Infectious Disease 5 (6), Suppl. S332-4.
12. Kenny, G. E., Hooton, T. M., Roberts, M. C., Cartwright, F. D. & Hoyt, J. (1989). Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrobial Agents and Chemotherapy 33, 103-7.
13. Bebear, C., Renaudin, H., Maugein, J., de Barbeyrac, B. & Clerc, M.-T. (1990). Pristinamycin and human mycoplasmas: in vitro activity compared with macrolides and lincosamides, in vivo efficacy in Mycoplasma pneumoniae experimental infection. In Recent Advances in Mycoplasmology (Stanek, G., Cassell, G. H., Tully, J. G. & Whitcomb, R. F., Eds) Zentralblatt für Bakteriologie, Suppl. 20, pp. 77-82. Gustav Fischer Verlag, Stuttgart.
14. Renaudin, H., Boussens, B. & Bebear, C. (1991). In vitro activity of RP59500 against mycoplasma. In Program and Abstracts of the Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy, Venice, 1991. Abstract 897, p. 248. American Society for Microbiology, Washington, DC.
15. Renaudin, H. & Bébéar, C. (1995). In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118. Drugs 49, Suppl. 2, 243-5.
16. Bébéar, C., Dupon, M., Renaudin, H. & de Barbeyrac, B. (1993). Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clinical Infectious Diseases 17, Suppl. 1, 202-7.
17. Renaudin, H., Aydin, M. D. & Bébéar, C. (1995). Ketolides and mycoplasmas: in vitro evaluation of RU 004. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco CA, 1995. Abstract F 168, p. 142. American Society for Microbiology, Washington, DC.
18. Renaudin, H., Tully, J. G. & Bebear, C. (1992). In vitro susceptibilities of Mycoplasma genitalium to antibiotics. Antimicrobial Agents and Chemotherapy 36, 870-2.
19. Koshimizu, K., Ito, M., Magaribuchi, T. & Kotani, H. (1983). Selective medium for isolation of ureaplasmas from animals. Japanese Journal of Veterinary Science 45, 263-8.
20. Hayes, M. M., Wear, D. J. & Lo, S.-C. (1991). In vitro antimicrobial susceptibility testing for the newly identified AIDS-associated Mycoplasma: Mycoplasma fermentans (incognitus strain). Archives of Pathology and Laboratory Medicine 115, 464-6.
21. Hannan, P. C. T. (1995). Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycosides in vitro. Journal of Medical Microbiology 42, 421-8.
22. Taylor-Robinson, D., Davies, H. A., Sarathchandra, P. & Furr, P. M. (1991). Intracellular location of mycoplasmas in cultured cells demonstrated by immunocytochemistry and electron microscopy. International Journal of Experimental Pathology 72, 705-714.
23. Mernaugh, C. R., Dallo, S. F., Holt, S. C. & Baseman, J. B. (1993). Properties of adhering and nonadhering populations of Mycoplasma genitalium. Journal of Clinical Infectious Diseases 17, Suppl. 1, S69-78.
24. Jensen, J. S., Blom, J. & Lind, K. (1994). Intracellular location of Mycoplasma genitalium in cultured Vero cells as demonstrated by electron microscopy. International Journal of Experimental Pathology 75, 91-8.
25. Baseman, J. B., Lange, M., Criscimagna, N. L., Giron, J. A. & Thomas, C. A. (1995). Interplay between mycoplasmas and host target cells. Microbial Pathogenesis 19, 105-16.
26. Mazzali, R. & Taylor-Robinson, D. (1971). The behaviour of T-mycoplasmas in tissue culture. Journal of Medical Microbiology 4, 125-38.
27. Gaurivaud, P., Laigret, F. & Bové, J. M. (1996). Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase β-subunit gene. Antimicrobial Agents and Chemotherapy 40, 858-62.
28. Fraser, C. M., Gocayne, J. D., White, O., Adams, M. D., Clayton, R. A., Fleischmann, R. D. et al. (1995). The minimal gene complement of Mycoplasma genitalium. Science 270, 397-403.
29. Editorial. (1990). Do human MLO exist? Lancet 335, 1068-9.
30. Johnson, L., Wirostko, E., Wirostko, W. & Wirostko, B. (1996). Mycoplasma-like organisms in Hodgkin's disease. Lancet 347, 901-2.
31. Taylor-Robinson, D. (1996). Mycoplasmas and oncogenesis. Lancet 347, 1555.
32. Blyth, W. A. (1958). An investigation into the aetiology of non-gonococcal urethritis with special reference to the role of pleuropneumonia-like organisms. PhD Thesis, University of London.
33. Lo, S.-C., Shih, J. W.-K., Newton, P. B., Wong, D. M., Hayes, M. M., Benish, J. R. et al. (1989). Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. American Journal of Tropical Medicine and Hygiene 41, 586-600.
34. Bébéar, C. M., Bové, J. M., Bébéar, C. & Renaudin, J. (1997). Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones. Antimicrobial Agents and Chemotherapy 41, 269-73.
35. Taylor-Robinson, D., Thomas, B. J., Furr, P. M. & Keat, A. C. (1983). The association of Mycoplasma hominis with arthritis. Sexually Transmitted Diseases 10, Suppl. 4, 341-4.
36. Bygdeman, S. M. & Mårdh, P.-A. (1983). Antimicrobial susceptibility and susceptibility testing of Mycoplasma hominis: a review. Sexually Transmitted Diseases 10, Suppl. 4, 366-70.
37. Koutsky, L. A., Stamm, W. E., Brunham, R. C., Stevens, C. E., Cole, B., Hale, J. et al. (1983). Persistence of Mycoplasma hominis after therapy: importance of tetracycline resistance and of coexisting vaginal flora. Sexually Transmitted Diseases 10, Suppl. 4, 374-81.
38. Roberts, M. C., Koutsky, L. A., Holmes, K. K., LeBlanc, D. L. & Kenny, G. E. (1985). Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences. Antimicrobial Agents and Chemotherapy 28, 141-3.
39. Taylor-Robinson, D. & Furr, P. M. (1986). Clinical antibiotic resistance of Ureaplasma urealyticum. Pediatric Infectious Diseases 5 (6), Suppl. S335-7.
40. Roberts, M. C. & Kenny, G. E. (1986). Dissemination of the tetM tetracycline-resistance determinant to Ureaplasma urealyticum. Antimicrobial Agents and Chemotherapy 29, 350-2.
41. Kenny, G. E. & Cartwright, F. D. (1994). Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines. Antimicrobial Agents and Chemotherapy 38, 2628-32.
42. Lucier, T. S., Heitzman, K., Liu, S. K. & Hu, P. C. (1995). Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrobial Agents and Chemotherapy 39, 2770-3.
43. Smith, C. B., Friedewald, W. T. & Chanock, R. M. (1967). Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. New England Journal of Medicine 276, 1172-5.
44. Furr, P. M., Taylor-Robinson, D. & Webster, A. D. B. (1994). Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years. Annals of the Rheumatic Diseases 53, 183-7.
45. Taylor-Robinson, D., Webster, A. D. B., Furr, P. M. & Asherson, G. L. (1980). Prolonged persistence of Mycoplasma pneumoniae in a patient with hypogammaglobulinaemia. Journal of Infection 2, 171-5.
46. Taylor-Robinson, D., Furr, P. M. & Webster, A. D. B. (1985). Ureaplasma urealyticum causing persistent urethritis in a patient with hypogammaglobulinaemia. Genitourinary Medicine 61, 404-8.
47. Webster, A. D. B., Taylor-Robinson, D., Furr, P. M. & Asherson, G. L. (1978). Mycoplasmal (ureaplasma) septic arthritis in hypogammaglobulinaemia. British Medical Journal i, 478-9.
48. Taylor-Robinson, D., Furr, P. M. & Webster, A. D. B. (1986). Ureaplasma urealyticum in the immunocompromised host. Pediatric Infectious Disease 5 (6), Suppl. S236-8.
49. Gelfand, E. W. (1993). Unique susceptibility of patients with antibody deficiency to mycoplasma infection. Clinical Infectious Diseases 17, Suppl. 1, S250-3.
50. McCoy, R. E., Caudwell, A., Chang, C. J., Chen, T. A., Chiykowski, L. N., Cousin, M. T. et al. (1989). Plant diseases associated with mycoplasma-like organisms. In The Mycoplasmas, Vol. 5 (Whitcomb, R. F. & Tully, J. G., Eds), pp. 545-640. Academic Press, New York.
51. Kingston, J. R., Chanock, R. M., Mufson, M. A., Hellman, L. P., James, W. D., Fox, H. H. et al. (1961). Eaton agent pneumonia. Journal of the American Medical Association 176, 118-23.
52. Shames, J. M., George, R. B., Holliday, W. B., Rasch, J. R. & Mogabgab, W. J. (1970) Comparison of antibiotics in the treatment of mycoplasmal pneumonia. Archives of Internal Medicine 125, 680-4.